<< Professor Suzanne Cory receives award for her work in cancer and immunogenetics | Los Angeles Jewish Home continues to meet nursing shortage in the country >>
Read in | English | Português | Svenska

DaVita to demonstrate clinical outcomes, patient care and nutrition through 43 abstracts

Published on October 24, 2009 at 7:16 AM · No Comments

DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD), in conjunction with DaVita Clinical Research®, today announced that company representatives will deliver 43 abstracts—40 posters and three oral presentations—at this year’s American Society of Nephrology’s (ASN) Renal Week to be held in San Diego, Calif., from Oct. 27 – Nov. 1, 2009.

The world’s largest nephrology meeting, ASN’s Renal Week celebrates leaders in nephrology research, clinical care and education. The meeting serves as a platform for the nation’s leading renal health care providers to learn about new developments in the field of nephrology and CKD. This year DaVita® will deliver three oral presentations:

  • Prescribing and Patient Factors Contributing to Adequate Hemodialysis Dose in Obese Patients
  • Nocturnal Hemodialysis improves hemoglobin sensitivity to Erythropoietin Therapy
  • Potassium Intake and Five-Year Mortality in Maintenance Hemodialysis Patients

“DaVita is continuing to lead the renal community in generating important new knowledge to improve outcomes for patients with kidney disease,” said Allen R. Nissenson, MD, FACP, Chief Medical Officer for DaVita. “This commitment to high-quality clinical research is clearly evident in the 43 abstracts being presented at Renal Week this year.”

Posters to be presented demonstrate a commitment to superior clinical outcomes, patient care, nutrition and more:

Access

  • Age and Access: A Large Dialysis Provider’s Perspective on an Advancing ESRD Population
  • Reducing the Catheter Rate: Results from the DaVita/SCAN Health Plan Medicare Demonstration Project

Adherence

  • Effect of IMPACT™ Program on Clinical Indicators of Incident Hemodialysis Patients
  • The Influence of participation in a Refill Management System within a Specialty Pharmacy on Control of Secondary Hyperparathyroidism among Prevalent Hemodialysis Patients
  • The Influence of a Specialty Pharmacy on Control of Secondary Hyperparathyroidism among Prevalent Hemodialysis Patients

CKD

  • Clinical Outcomes of Patients Completing Early CKD Education
  • First-Year Dialysis Outcomes in Patients Previously Enrolled in a Structured Chronic Kidney Disease (CKD) Program: Matched Cohort Analysis

Disparity

  • Clinical Characteristics Differ among Hemodialysis Patients of Various Racial and Ethnic Groups
  • Potential Impacts of Proposed Bundling System on Active Vitamin D Administration for African American Hemodialysis Patients

Fluid Management/Hypertension (SDHD)

  • Hypertension and Fluid Dynamics in Patients Undergoing Short Daily versus Conventional Hemodialysis

Hospitalization (Modality)

  • Impact of Dialysis Modality on Hospitalization in Patients with ESRD

Infection

  • Improving Influenza Vaccination Rates among Dialysis Patients: Results of a Quality Management Program in a Large Dialysis Population

Laboratory Operations

  • Evidence of Between-Laboratory Bias Raises Questions about Reliability of Potential Test Results to Be Used in Pay-for-Performance

Mortality

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading